Hong Zhe

1.2k total citations
26 papers, 981 citations indexed

About

Hong Zhe is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Hong Zhe has authored 26 papers receiving a total of 981 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 12 papers in Oncology and 5 papers in Surgery. Recurrent topics in Hong Zhe's work include Genomics, phytochemicals, and oxidative stress (6 papers), Colorectal Cancer Surgical Treatments (3 papers) and Inflammatory Biomarkers in Disease Prognosis (3 papers). Hong Zhe is often cited by papers focused on Genomics, phytochemicals, and oxidative stress (6 papers), Colorectal Cancer Surgical Treatments (3 papers) and Inflammatory Biomarkers in Disease Prognosis (3 papers). Hong Zhe collaborates with scholars based in China, United States and Australia. Hong Zhe's co-authors include Ren Zhao, Yanyang Wang, Yanyang Wang, Zhoulan Bai, Yinxue Yang, Di Xia, Shun Zhou, Zhijun Zhao, Zhixu He and Shu-Feng Zhou and has published in prestigious journals such as Free Radical Biology and Medicine, International Journal of Radiation Oncology*Biology*Physics and Molecular Cancer.

In The Last Decade

Hong Zhe

24 papers receiving 973 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hong Zhe China 13 745 266 185 71 68 26 981
Wuguo Li China 16 569 0.8× 272 1.0× 192 1.0× 78 1.1× 85 1.3× 31 842
Runping Fang China 18 733 1.0× 403 1.5× 154 0.8× 70 1.0× 82 1.2× 26 943
Ulrike Begley United States 11 998 1.3× 280 1.1× 114 0.6× 73 1.0× 49 0.7× 15 1.3k
Wan‐Xin Peng China 19 953 1.3× 610 2.3× 163 0.9× 76 1.1× 58 0.9× 40 1.3k
Imoh S. Okon United States 13 425 0.6× 187 0.7× 97 0.5× 97 1.4× 108 1.6× 20 725
Vimal Pandey India 16 409 0.5× 180 0.7× 185 1.0× 51 0.7× 59 0.9× 26 779
Yi Xiao China 19 668 0.9× 344 1.3× 316 1.7× 135 1.9× 79 1.2× 71 1.1k
Mudan Lu China 17 564 0.8× 199 0.7× 136 0.7× 118 1.7× 108 1.6× 36 856
Xinyan Li China 14 519 0.7× 299 1.1× 248 1.3× 66 0.9× 68 1.0× 37 917

Countries citing papers authored by Hong Zhe

Since Specialization
Citations

This map shows the geographic impact of Hong Zhe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong Zhe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong Zhe more than expected).

Fields of papers citing papers by Hong Zhe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hong Zhe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong Zhe. The network helps show where Hong Zhe may publish in the future.

Co-authorship network of co-authors of Hong Zhe

This figure shows the co-authorship network connecting the top 25 collaborators of Hong Zhe. A scholar is included among the top collaborators of Hong Zhe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hong Zhe. Hong Zhe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Liu, Shiwei, Junhong Li, Junyu Zhang, et al.. (2024). IKBKE regulates renal cell carcinoma progression and sunitinib resistance through the RRM2-AKT pathway. International Journal of Biological Sciences. 20(15). 6146–6161. 1 indexed citations
3.
4.
Wen, Rui, Miaoran Wang, Wei Bian, et al.. (2023). Machine learning-based prediction of symptomatic intracerebral hemorrhage after intravenous thrombolysis for stroke: a large multicenter study. Frontiers in Neurology. 14. 1247492–1247492. 5 indexed citations
5.
Niture, Suryakant, Minghui Lin, John T. Moore, et al.. (2020). TNFAIP8 drives metabolic reprogramming to promote prostate cancer cell proliferation. The International Journal of Biochemistry & Cell Biology. 130. 105885–105885. 9 indexed citations
6.
Zhang, Li, Shiyu Zhang, Huajian Chen, et al.. (2020). An acoustic/thermo-responsive hybrid system for advanced doxorubicin delivery in tumor treatment. Biomaterials Science. 8(8). 2202–2211. 15 indexed citations
7.
Ding, Zhe, et al.. (2019). The role of neutrophil-to-lymphocyte ratio (NLR) in predicting small bowel toxicity and outcome for rectal cancer patients who received chemoradiotherapy. Iranian Journal of radiation research. 17(2). 309–315. 1 indexed citations
8.
Zhang, Cuiying, et al.. (2019). Prognostic Value of Combined Analysis of CTLA-4 and PLR in Esophageal Squamous Cell Carcinoma (ESCC) Patients. Disease Markers. 2019. 1–7. 10 indexed citations
9.
Bian, Chao, Wenjun Qin, Cuiying Zhang, et al.. (2018). Thalidomide (THD) alleviates radiation induced lung fibrosis (RILF) via down-regulation of TGF-β/Smad3 signaling pathway in an Nrf2-dependent manner. Free Radical Biology and Medicine. 129. 446–453. 27 indexed citations
10.
Zhou, Shun, Zhoulan Bai, Di Xia, et al.. (2018). FTO regulates the chemo‐radiotherapy resistance of cervical squamous cell carcinoma (CSCC) by targeting β‐catenin through mRNA demethylation. Molecular Carcinogenesis. 57(5). 590–597. 294 indexed citations
11.
Wang, Yanyang, Juan Chen, Xiaoming Liu, Ren Zhao, & Hong Zhe. (2018). Nrf2‐Mediated Metabolic Reprogramming in Cancer. Oxidative Medicine and Cellular Longevity. 2018(1). 9304091–9304091. 53 indexed citations
12.
Zhao, Ren, Wei Kong, Jun Shang, Hong Zhe, & Yanyang Wang. (2016). Hippocampal-Sparing Whole-Brain Radiotherapy for Lung Cancer. Clinical Lung Cancer. 18(2). 127–131. 13 indexed citations
13.
14.
Zhou, Shufeng, Yanyang Wang, Yinxue Yang, et al.. (2015). Bardoxolone methyl induces apoptosis and autophagy and inhibits epithelial-to-mesenchymal transition and stemness in esophageal squamous cancer cells. Drug Design Development and Therapy. 9. 993–993. 34 indexed citations
15.
Wang, Yanyan, Hong Zhe, & Ren Zhao. (2014). Preclinical evidences toward the use of triterpenoid CDDO-Me for solid cancer prevention and treatment. Molecular Cancer. 13(1). 30–30. 67 indexed citations
16.
Zhou, Shu-Feng, Yanyang Wang, Hong Zhe, Yinxue Yang, & Zhixu He. (2014). Bardoxolone methyl (CDDO-Me) as a therapeutic agent: an update on its pharmacokinetic and pharmacodynamic properties. Drug Design Development and Therapy. 8. 2075–2075. 207 indexed citations
17.
Zhe, Hong, et al.. (2013). Clinical application of multimodality imaging in radiotherapy treatment planning for rectal cancer. Cancer Imaging. 13(4). 495–501. 6 indexed citations
18.
19.
Zhe, Hong. (2007). Association of the C3435T polymorphism in the multidrug resistance gene 1 and response to antiepileptic drug treatment in epilepsy patients. 1 indexed citations
20.
Zhe, Hong. (2006). An intronic cholesterol 24S-hydroxylase polymorphism associated with Alzheimer disease. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wuguo Li Breakdown of academic impact, for papers by Runping Fang Breakdown of academic impact, for papers by Ulrike Begley Breakdown of academic impact, for papers by Wan‐Xin Peng Breakdown of academic impact, for papers by Imoh S. Okon Breakdown of academic impact, for papers by Vimal Pandey Breakdown of academic impact, for papers by Yi Xiao Breakdown of academic impact, for papers by Mudan Lu Breakdown of academic impact, for papers by Xinyan Li
Rankless by CCL
2026